Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448 54. 453. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treat- ment of infarcting myocardium early II trial substudy. Circulation. 2000;102:2031 7. 454. French JK, Feldman HA, Assmann SF, et al. Influence of thrombo- lytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J. 2003;146:804 10. 455. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933 9. 456. Chen EW, Canto JG, Parsons LS, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation. 2003;108:951 7. 457. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra- aortic balloon pump counterpulsation, and their combination in cardio- genic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000;36:1123 9. 458. Sjauw KD, Engstr m AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30:459 68. 459. Ohman EM, Nanas J, Stomel RJ, et al. Thrombolysis and counterpulsa- tion to improve survival in myocardial infarction complicated by hypo- tension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005;19:33 9. 460. Dzavik V, Sleeper LA, Cocke TP, et al. 